Guide to nobiletin and eriodictyol potent citrus flavonoids that combat inflammation, support antioxidant defenses, and attenuate endotoxin-induced inflammatory signaling.
Independent · Mechanism-First · Evidence-Graded
Measslainte
Clearance, tolerance, and recovery in chronic illness
Independent research on chronic post-viral and post-vaccination illness. The clearance-and-tolerance framework, pathway mechanics, stratified biomarkers, and the natural compounds that act as levers within it.
Latest Research
Investigations into natural compounds, cellular health mechanisms, and evidence-based wellness protocols.
Featured: The Spikeopathy Research Cluster
The most developed work on this site. A unified framework for chronic spike-related illness as systemic clearance and tolerance failure under persistent antigenic drive: pathway mechanics (mTOR, glymphatic, SIRT1), five mechanistic subtypes, a tiered biomarker matrix, and intervention protocols. Evidence-graded, primary-source, falsifiable.
Personalized Health Restoration: A Framework for Post-Pandemic Recovery
Your biology is unique. What helps one person recover may not help you or could make things worse. This framework guides you through systematic assessment and targeted interventions based on your specific health terrain.
Spikeopathy Stratified: Five Mechanistic Subtypes, a Tiered Biomarker Matrix, and What Would Falsify the Framework
A companion to the spikeopathy pathways article. Five mechanism-based subtypes instead of one umbrella hypothesis, a four-tier UK biomarker matrix mapped to each subtype, and an explicit falsifiability section. The differentiator: nobody has tried comprehensive PASC subtyping by clearance/tolerance mechanism before.
Spikeopathy Pathways: mTOR, Glymphatic Clearance, and the SIRT1/PGC-1α Axis
The clearance-system failure hypothesis of spikeopathy. Two systems break together: mTOR-driven autophagy inside cells, and glymphatic flow between them. SIRT1/PGC-1α is the connecting axis. With 2025 DTI-ALPS imaging, the dual-mTOR model, and the levers that actually touch the cycle.
A Foundational mRNA Assumption Under Challenge: What the 2025 Nature Biotechnology Paper Actually Shows
THE mRNA PLATFORM JUST COLLAPSED Nature Biotechnology just published a paper proving the entire mRNA vaccine platform was built on a scientifically false foundation. The technology to prevent cardiac damage has existed since 2006. It was never incorporated. ...
Bioinformatics Analysis: Codon Optimization Signatures in COVID-19 mRNA Vaccines vs Natural Variants
Comprehensive computational analysis reveals artificial codon preference changes in COVID-19 mRNA vaccines (Pfizer: 15%, Moderna: 35%) absent from all natural SARS-CoV-2 variants (0%).
Testing Perez's 2P Numerical Anomaly: Statistical Analysis of mRNA Vaccine Spike Sequences
Declaration of Purpose This article presents a bioinformatics validation of Jean-Claude Perez's Supracode methodology, enhanced with modern structural biology and frameshifting research. All data are from public sequences and peer-reviewed sources. ...
Failed Resolution: An Evidence-Graded Case for Pausing the mRNA Platform
Manufacturing switch, DNA contamination, spike persistence, IgG4 immune tolerance, amyloid microclots, and regulatory failure converge on one conclusion: mRNA experiments must halt until safety is demonstrated.
Intranasal Vaccine Brain Risk: The 2026 BPL-1357 Policy Playing Out
The scientific case for pausing NIAID's intranasal whole-virus platforms: direct olfactory-nerve access to the brain, full structural proteins including spike, and the exact networks mapped in 2025 now running U.S. policy.
Spike Protein Gain of Function: Why mRNA Injections Aren't Vaccines | Dr. Typhaine Pinsolle
Dr. Typhaine Pinsolle breaks down the Spike protein's engineered structure with HIV inserts, furin cleavage site, SV40 promoters, and why COVID mRNA injections don't meet the definition of a vaccine.
Post-Pandemic Opportunistic Infections: Beyond Candida
A comprehensive clinical analysis of how COVID-19 disrupts immune function and microbiome balance, increasing susceptibility to secondary infections beyond common fungal pathogens, with special attention to emerging post-intervention syndromes.
Beyond Blood Clots: PAD4, mRNA Technology, and the Calamari Thrombosis Hypothesis
Molecular analysis of unusual 'calamari clots' reveals connections between lipid nanoparticles, PAD4 citrullination, and treatment-resistant thrombosis. Limited human evidence; proteomic data from investigator reports requires validation.